Yes. As of the latest regulator updates, Botulinum Toxin Type B has 1 active shortage notice across 1 country (Iceland). Status is refreshed daily from official regulatory sources.
Why is Botulinum Toxin Type B in shortage?
Regulators attribute the current Botulinum Toxin Type B shortages to causes not stated by the regulator. The exact cause varies by country and product — each notice on this page links to the official source.
Where does this Botulinum Toxin Type B shortage data come from?
Every shortage notice on this page is scraped daily from an official national medicines regulator (such as the FDA, TGA, MHRA or EMA) and linked back to its source. Mederti aggregates 40+ regulators across 50+ countries and never publishes unsourced shortage claims.
Get alerted when Botulinum Toxin Type B status changes
Free for individual pharmacists and clinicians — watchlists, email alerts, alternatives and country-by-country product detail.
Data on this page is aggregated from official national medicines regulators and updated daily. It is provided for information only and requires verification before clinical use. Mederti is not affiliated with or endorsed by any regulator.